| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Airborne infectious disease and the suppression of pulmonary bioaerosols
|
Fiegel, Jennifer
|
|
2006
|
11 |
1-2 |
p. 51-57
7 p.
|
artikel
|
| 2 |
Computational chemistry-driven decision making in lead generation
|
Schnecke, Volker
|
|
2006
|
11 |
1-2 |
p. 43-50
8 p.
|
artikel
|
| 3 |
Elimination mechanisms of therapeutic monoclonal antibodies
|
Tabrizi, Mohammad A.
|
|
2006
|
11 |
1-2 |
p. 81-88
8 p.
|
artikel
|
| 4 |
Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
|
Xie, Frank Y.
|
|
2006
|
11 |
1-2 |
p. 67-73
7 p.
|
artikel
|
| 5 |
Human glial cell culture models of inflammation in the central nervous system
|
van Noort, Johannes M.
|
|
2006
|
11 |
1-2 |
p. 74-80
7 p.
|
artikel
|
| 6 |
Mining chemical structural information from the drug literature
|
Banville, Debra L.
|
|
2006
|
11 |
1-2 |
p. 35-42
8 p.
|
artikel
|
| 7 |
Monitor
|
Barlocco, Daniela
|
|
2006
|
11 |
1-2 |
p. 89-
1 p.
|
artikel
|
| 8 |
MRI-guided immunotherapy development for multiple sclerosis in a primate
|
't Hart, Bert A.
|
|
2006
|
11 |
1-2 |
p. 58-66
9 p.
|
artikel
|
| 9 |
New drug candidates and therapeutic targets for tuberculosis therapy
|
Zhang, Ying
|
|
2006
|
11 |
1-2 |
p. 21-27
7 p.
|
artikel
|
| 10 |
Pharmacogenomics: an in-house advantage?
|
Borchardt, Paul E.
|
|
2006
|
11 |
1-2 |
p. 1-3
3 p.
|
artikel
|
| 11 |
The potential impact of structural genomics on tuberculosis drug discovery
|
Arcus, Vickery L.
|
|
2006
|
11 |
1-2 |
p. 28-34
7 p.
|
artikel
|
| 12 |
The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets
|
Myers, Robert R.
|
|
2006
|
11 |
1-2 |
p. 8-20
13 p.
|
artikel
|
| 13 |
Using epidemiology and archaeology to unearth new drug targets for rheumatoid arthritis therapy
|
Mobley, James L.
|
|
2006
|
11 |
1-2 |
p. 4-7
4 p.
|
artikel
|
Tijdschrift beschrijving